Targeting TBP-Associated Factors in Ovarian Cancer - Wikidata - wikimedia - TriplyDB

Targeting TBP-Associated Factors in Ovarian Cancer

Targeting TBP-Associated Factors in Ovarian Cancer

http://www.wikidata.org/entity/Q26866045

about

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasion Targeted alternative splicing of TAF4: a new strategy for cell reprogramming.Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype.Increased global transcription activity as a mechanism of replication stress in cancer MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists Zinc knuckle of TAF1 is a DNA binding module critical for TFIID promoter occupancy.Genomic alterations of ground-glass nodular lung adenocarcinoma.Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival An interaction network driven approach for identifying biomarkers for progressing cervical intraepithelial neoplasia

P2860

Q26777453-3DEAA7BD-F3E8-4D09-8CC2-4C6D7DF90231 Q36838910-345DED84-E30F-4815-ABF6-FD0BB26D1DA7 Q37157426-C70CCDFD-C35F-4A3B-875E-8C443EE46FAF Q37625774-EF8CE600-1391-498B-916F-C0BCD2896133 Q41450696-9C0517BD-114C-4CD5-BE48-022A96225BD6 Q42380563-90B47096-6D5D-4728-AE8D-45DE91E80F46 Q52353785-68C34C0D-4238-4F13-B6E0-28FE9A0099EF Q54209531-D3C53868-2CBD-4E6A-AF3C-86E5C98C9557 Q58115551-BB424E9D-ED07-41F8-A269-76CEDBAE1F14 Q58701379-398D3DA1-A2FF-4E88-9E8A-8AA54CC0F616

P2860

Targeting TBP-Associated Factors in Ovarian Cancer

http://www.wikidata.org/entity/Q26866045

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Targeting TBP-Associated Factors in Ovarian Cancer

@ast

Targeting TBP-Associated Factors in Ovarian Cancer

@en

Targeting TBP-Associated Factors in Ovarian Cancer

@nl

type

label

Targeting TBP-Associated Factors in Ovarian Cancer

@ast

Targeting TBP-Associated Factors in Ovarian Cancer

@en

Targeting TBP-Associated Factors in Ovarian Cancer

@nl

prefLabel

Targeting TBP-Associated Factors in Ovarian Cancer

@ast

Targeting TBP-Associated Factors in Ovarian Cancer

@en

Targeting TBP-Associated Factors in Ovarian Cancer

@nl

P1433

Q26866045-35E3ACB1-3E05-42BB-B6EB-D112EFBAA454

P1476

Q26866045-D129743A-B34D-4851-8B64-26B6F6C57987

P2093

Q26866045-BCBAB9E5-160F-4F28-AF7A-545AF277A915

Q26866045-C8F04BC8-C4E7-4251-82CD-57F11470E140

Q26866045-D7EF782F-1C37-432D-8C09-BEC310B69002

Q26866045-FAE89D4E-3F71-436D-A7FF-A5760D48BB23

P2860

Q26866045-00972B4A-1427-405D-AB79-191CF408F20A

Q26866045-00AD604F-27C5-419D-8BDC-A39A175F30A4

Q26866045-05B360F6-9866-4AD2-B26D-572DB8BC54AC

Q26866045-0600754D-CF76-4830-93B8-BC66E310ECF1

Q26866045-06D2EB06-882F-48CD-AD6D-0BD4971CFCDD

Q26866045-08F9A379-91D4-43C2-B20B-70DF39786800

Q26866045-0CC988FF-C19C-48F1-92D0-5021EB111C79

Q26866045-0EB7871E-6D01-449B-8CAA-20D263EF069D

Q26866045-10411AB6-65CD-4609-B3E9-834F34757F9D

Q26866045-1109230D-3E69-4611-9321-0F8D31F555BC

P304

Q26866045-63EA9053-70A1-431B-BF69-848B8193894B

P31

Q26866045-C06B7C4C-7DC2-4467-89B2-6333B69D4E9C

P3181

Q26866045-8D973D8C-F89C-4B2D-87A5-8083508C9B2F

P356

Q26866045-457C438F-DF4F-4541-97EA-233E61F78FFE

P407

Q26866045-5E81D1F1-8CDB-49D0-B0E4-3430B51913FA

P478

Q26866045-756F7A7D-77CC-435C-9870-7D1FDCC8BEF0

P577

Q26866045-53DA044A-043D-4556-8FD2-6C21AEF31399

P5875

Q26866045-D3370A24-B2A2-451A-8504-559E4E3A6AB4

P698

Q26866045-54E106E3-163F-4EA0-911A-31B08EDAC8CB

P921

Q26866045-FE16D926-B9EE-4AA6-8897-00FE5922B0E3

P932

Q26866045-CE2E20D8-AC0B-414D-B2F9-3D7D6E8E210E

P3181

P356

FONC.2014.00045

P1433

Frontiers in Oncology

P1476

Targeting TBP-Associated Factors in Ovarian Cancer

@en

P2093

Barbara C. Vanderhyden

http://www.w3.org/2001/XMLSchema#string

Jennifer R. Ribeiro

http://www.w3.org/2001/XMLSchema#string

Lindsay A. Lovasco

http://www.w3.org/2001/XMLSchema#string

Richard N. Freiman

http://www.w3.org/2001/XMLSchema#string

P2860

Stabilization and activation of p53 by the coactivator protein TAFII31

TAF7 (TAFII55) plays a role in the transcription activation by c-Jun

TAFII70 isoform-specific growth suppression correlates with its ability to complex with the GADD45a protein

Functional analysis of the human TAFII250 N-terminal kinase domain

High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation

Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II

Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression

TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB

Mammalian TAF(II)30 is required for cell cycle progression and specific cellular differentiation programmes

DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250-TAF(II)150 complex recognizes the initiator

P304

45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3051197

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FONC.2014.00045

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261000076

http://www.w3.org/2001/XMLSchema#string

P698

24653979

http://www.w3.org/2001/XMLSchema#string

P921

P932

3949196

http://www.w3.org/2001/XMLSchema#string